| CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 R Amraei, W Yin, MA Napoleon, EL Suder, J Berrigan, Q Zhao, J Olejnik, ... ACS Central Science 7 (7), 1156-1165, 2021 | 326 | 2021 |
| CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses S Jalloh, J Olejnik, J Berrigan, A Nisa, EL Suder, H Akiyama, M Lei, ... PLoS pathogens 18 (10), e1010479, 2022 | 31 | 2022 |
| Diminished Capsule Exacerbates Virulence, Blood–Brain Barrier Penetration, Intracellular Persistence, and Antibiotic Evasion of Hyperhemolytic Group B Streptococci C Gendrin, S Merillat, J Vornhagen, M Coleman, B Armistead, L Ngo, ... The Journal of infectious diseases 217 (7), 1128-1138, 2018 | 19 | 2018 |
| Novel ELISA protocol links pre-existing SARS-CoV-2 reactive antibodies with endemic coronavirus immunity and age and reveals improved serologic identification of acute COVID-19 … RR Yuen, D Steiner, RMF Pihl, E Chavez, A Olson, EL Smith, LA Baird, ... Frontiers in immunology 12, 614676, 2021 | 18 | 2021 |
| Multidose evaluation of 6,710 drug repurposing library identifies potent SARS-CoV-2 infection inhibitors In Vitro and In Vivo JJ Patten, PT Keiser, D Gysi, G Menichetti, H Mori, CJ Donahue, X Gan, ... bioRxiv, 2021.04. 20.440626, 2021 | 12* | 2021 |
| Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritization JJ Patten, PT Keiser, D Morselli-Gysi, G Menichetti, H Mori, CJ Donahue, ... Iscience 25 (9), 2022 | 10 | 2022 |
| CD209L/L-SIGN and CD209 R Amraei, W Yin, MA Napoleon, EL Suder, J Berrigan, Q Zhao, J Olejnik, ... DC‑SIGN act as receptors for SARS‑CoV‑2, 2021 | 9 | 2021 |
| CD209L/L-SIGN and CD209/DCSIGN Act as Receptors for SARS-CoV-2. ACS Cent Sci. 2021; 7: 1156–1165 R Amraei, W Yin, MA Napoleon, EL Suder, J Berrigan, Q Zhao | 5 | |
| SARS-CoV-2 reactive antibodies in unexposed individuals revealed by a high sensitivity, low noise serologic assay RR Yuen, D Steiner, RMF Pihl, E Chavez, A Olson, LA Baird, F Korkmaz, ... MedRxiV, 2020.09. 15.20192765, 2020 | 2 | 2020 |
| Crimean-Congo Hemorrhagic Fever Survivors Elicit Protective Non-Neutralizing Antibodies that Target 11 Overlapping Regions on Viral Glycoprotein GP38 OS Shin, SR Monticelli, CK Hjorth, V Hornet, M Doyle, D Abelson, ... bioRxiv, 2024 | 1 | 2024 |
| RESTRICTED INFECTION of MACROPHAGES by SARS-CoV-2 INDUCES PROINFLAMMATORY RESPONSES S Jalloh, J Olejnik, J Berrigan, EL Suder, A Nisa, S Tyagi, Y Bushkin, ... Topics in Antiviral Medicine, 64-64, 2022 | | 2022 |
| CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses (preprint) S Jalloh, J Olejnik, J Berrigan, A Nisa, EL Suder, H Akiyama, M Lei, ... | | 2022 |
| An ELISA protocol with resolution at high sample concentration reveals reactive antibodies to SARS-CoV-2 in unexposed individuals R Yuen, D Steiner, R Pihl, E Chavez, A Olson, L Baird, F Korkmaz, P Urick, ... | | 2020 |
Suryaram GummuluruBoston University School of Medicine在 bu.edu 的电子邮件经过验证
